Hot Topics in Patent Law: Non-Obviousness of Chemical and Pharmaceutical Patents

August 6, 2015

Logo for The Creator's Code

The world of patent law is constantly changing and it can pay to keep on top of things. Join us as Justin Hasford explores the recent decisions from the Court of Appeals for the Federal Circuit concerning the non-obviousness of patent claims directed to chemical and pharmaceutical innovations.

What You Will Learn

  • Mere similarity between a patented chemical composition and a prior art chemical composition does not render the patented invention invalid as obvious.
  • Prior art that addresses a different problem does not render a patented invention invalid as obvious.
  • An overly narrow statement of the problem, or defining the problem in terms of the patented solution, is an improper form of hindsight and does not render a patented invention invalid as obvious.

The Fine Print

ACS Webinars® does not endorse any products or services. The views expressed in this presentation are those of the presenters and do not necessarily reflect the views or policies of the American Chemical Society.

ACS Webinars Logo


Justin Hasford
Finnegan Henderson Farabow Garrett & Dunner

David Harwell
ACS Industry Members Programs

Co-Produced With